Trans-histone crosstalk establishes distinct H3K79 methylation zones with differential transcriptional functions
Nucleic Acids Research · 19.03.2026 · 54 (6)
DOI: 10.1093/nar/gkag291 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 02.04.2026. Verfasst von Na Hyun Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences and Multitasking Macrophage Research Center, Ewha Womans University, Seoul 03760, Republic of Korea. Hauptthemen laut MEDLINE: Histones, Saccharomyces cerevisiae Proteins, Transcription, Genetic, Gene Expression Regulation, Fungal. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation, Brain Korea 21 (BK21) FOUR Program.
Abstract (Originalsprache)
H3K79 methylation by Dot1 (disruptor of telomeric silencing-1) plays critical roles in multiple cellular processes potentially by modulating chromatin structure and gene expression. However, the genome-wide distribution patterns of H3K79me1, H3K79me2, and H3K79me3 and the mechanisms specifying these patterns remain unclear. Here, we mapped H3K79 methylation patterns across the yeast genome using ChIP-seq and identified three distinct gene groups, termed state-specific methylation zones, each predominantly marked by one methylation state. These zones remain largely stable during transcriptional reprogramming. They may be established and/or maintained via H2B ubiquitination by the Rad6–Bre1 complex: loss of Rad6 leads to the complete loss of the H3K79me3 zone, converting it into an H3K79me1-enriched region while simultaneously diminishing the H3K79me1 zone. Loss of H4K16 acetylation also similarly disrupted the H3K79me1 zone, albeit weakly. Interestingly, Dot1 occupancy does not always correlate with the H3K79me3 level, as translation-related genes exhibit high Dot1 occupancy but are depleted of H3K79me3. Functionally, H3K79me3 and H3K79me1 appear to play differential roles in transcriptional regulation: Dot1-activated genes are enriched for H3K79me3, whereas a majority of Dot1-repressed genes are associated with H3K79me1. We therefore propose that H3K79 methylation states define specific chromatin zones that contribute to differential transcriptional outputs and whose establishment and maintenance depend on trans-histone crosstalk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences and Multitasking Macrophage Research Center, Ewha Womans University, Seoul 03760, Republic of Korea.
- Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Republic of Korea.
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Department of Molecular Bioscience, College of Biomedical Science, Kangwon National University, Chuncheon 24341, Republic of Korea.
- Multidimensional Genomics Research Center, Kangwon National University, Chuncheon 24341, Republic of Korea.
ORCID-Profile: Yong-Joon Cho, Jae-Seok Roe, TaeSoo Kim
Förderung
- National Research Foundation
- Brain Korea 21 (BK21) FOUR Program
Zitieren
APA
Park, N. H., Kim, H. R., Kim, H. Y., Lee, S. Y., Cho, Y. J., Roe, J. S., & Kim, T. (2026). Trans-histone crosstalk establishes distinct H3K79 methylation zones with differential transcriptional functions. Nucleic Acids Research, 54(6). https://doi.org/10.1093/nar/gkag291
Vancouver
Park NH, Kim HR, Kim HY, Lee SY, Cho YJ, Roe JS, et al. Trans-histone crosstalk establishes distinct H3K79 methylation zones with differential transcriptional functions. Nucleic Acids Research. 2026;54(6). doi:10.1093/nar/gkag291
BibTeX
@article{Park2026,
author = {Park, Na Hyun and Kim, Hwa-Ryeon and Kim, Hye Young and Lee, Soo Young and Cho, Yong-Joon and Roe, Jae-Seok and Kim, TaeSoo},
title = {Trans-histone crosstalk establishes distinct H3K79 methylation zones with differential transcriptional functions},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {6},
doi = {10.1093/nar/gkag291}
}
EUVIMED